This new study from Venture Planning Group contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testig for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
France Market Overview
Market Segmentation Analysis
Five-year test volume and sales projections:
Opportunities and Strategic Recommendations
SIMILAR MARKET STUDIES
Blood Market by Product [Whole Blood Collection (System and Reagents), Source Plasma Collections (System and Reagents) Blood Therapeutics (IVIG, Albumin, Hyperimmune, Factor VIII, Factor IX, and Others), Blood Typing Products (System and Reagents), Blood Screening (Systems and Reagents), Blood Processing Equipment & Associated Products (System and Reagents)] and End User (Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2023
Blood is a major necessity for patients suffering from injuries and viral infections, which require blood transfusion. The patients are either given whole blood or blood components for quick recovery and healing, resulting into increased demand for blood banks.
July 2017 | $5370 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research